Stock THYROCARE THYROCARE TECHNOLOGIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Thyrocare Technologies Limited

Equities

THYROCARE

INE594H01019

Healthcare Facilities & Services

Market Closed - Bombay S.E.
Other stock markets
 06:00:48 2024-05-10 EDT 		5-day change 1st Jan Change
625.7 INR +0.55% Intraday chart for Thyrocare Technologies Limited -0.97% -2.77%
05-10 India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand RE
04-16 Thyrocare Technologies Limited Announces Resignation of Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 28,010 26,183 47,743 40,934 22,744 33,132 - -
Enterprise Value (EV) 1 27,190 25,464 46,565 39,750 21,429 33,132 33,132 33,132
P/E ratio 33.3 x 29.7 x 42.3 x 23.3 x 35.4 x 44.4 x 36.6 x 29.2 x
Yield 3.77% - 2.77% 1.94% 4.19% 1.36% 1.65% 2.06%
Capitalization / Revenue 6.95 x 6.04 x 9.65 x 6.95 x 4.32 x 5.87 x 5.23 x 4.51 x
EV / Revenue 6.95 x 6.04 x 9.65 x 6.95 x 4.32 x 5.87 x 5.23 x 4.51 x
EV / EBITDA 18.2 x 15.2 x 27.9 x 17.4 x 18.9 x 23.5 x 20.2 x 16.8 x
EV / FCF 46,636,130 x 16,599,924 x 54,228,709 x 5,415,977 x - - - -
FCF Yield 0% 0% 0% 0% - - - -
Price to Book 6.44 x 7.14 x 11.2 x 7.77 x - 5.87 x 5.52 x 5.13 x
Nbr of stocks (in thousands) 52,799 52,836 52,874 52,903 52,930 52,953 - -
Reference price 2 530.5 495.6 903.0 773.8 429.7 625.7 625.7 625.7
Announcement Date 19-05-18 20-05-23 21-05-08 22-04-29 23-05-23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,029 4,332 4,946 5,889 5,267 5,649 6,338 7,347
EBITDA 1 1,542 1,725 1,712 2,349 1,200 1,409 1,639 1,970
EBIT 1 1,281 1,406 1,410 2,008 813.4 979 1,164 1,463
Operating Margin 31.78% 32.46% 28.5% 34.11% 15.44% 17.33% 18.37% 19.91%
Earnings before Tax (EBT) 1 1,374 1,399 1,525 2,277 - 1,025 1,243 1,551
Net income 1 851.4 884.1 1,131 1,761 644.9 747 906 1,131
Net margin 21.13% 20.41% 22.87% 29.91% 12.24% 13.22% 14.29% 15.39%
EPS 2 15.91 16.71 21.37 33.24 12.14 14.10 17.10 21.40
Free Cash Flow 600.6 1,577 880.4 7,558 - - - -
FCF margin 14.91% 36.41% 17.8% 128.35% - - - -
FCF Conversion (EBITDA) 38.94% 91.43% 51.41% 321.77% - - - -
FCF Conversion (Net income) 70.54% 178.41% 77.82% 429.09% - - - -
Dividend per Share 2 20.00 - 25.00 15.00 18.00 8.500 10.30 12.90
Announcement Date 19-05-18 20-05-23 21-05-08 22-04-29 23-05-23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 1,383 1,468 1,646 1,762 1,174 1,306 1,278 1,350 1,280 1,359 1,349 1,482 1,497 1,492
EBITDA 1 496.2 515.3 712.3 892.9 368 375.9 359.2 315.8 283.5 - 343.1 394 390.5 390.5
EBIT 1 - 437.2 639.4 811.3 280 284.4 273.1 224.3 182 138.9 246.8 - - -
Operating Margin - 29.77% 38.83% 46.04% 23.85% 21.78% 21.37% 16.62% 14.22% 10.22% 18.3% - - -
Earnings before Tax (EBT) - - 738.1 956.3 289 - - - - - - - - -
Net income 1 - 377.5 555.8 777.3 215 212.4 217.3 154.3 147.2 - 173 217 231.5 251
Net margin - 25.71% 33.76% 44.11% 18.31% 16.27% 17% 11.43% 11.5% - 12.83% 14.65% 15.46% 16.83%
EPS - - - - 4.050 - 4.100 3.800 1.880 - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 21-01-30 21-05-08 21-08-12 21-11-13 22-02-12 22-04-29 22-08-01 22-11-11 23-02-04 23-05-23 23-08-01 - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 820 720 1,178 1,184 1,315 - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 601 1,577 880 7,558 - - - -
ROE (net income / shareholders' equity) 19.4% 22.1% 28.5% 36.9% 12.2% 13.6% 15.6% 18.2%
ROA (Net income/ Total Assets) - - - 30.5% - - - -
Assets 1 - - - 5,767 - - - -
Book Value Per Share 2 82.40 69.40 80.80 99.50 - 107.0 113.0 122.0
Cash Flow per Share - - - - - - - -
Capex 1 403 99 283 378 - 510 300 300
Capex / Sales 9.99% 2.29% 5.71% 6.42% - 9.03% 4.73% 4.08%
Announcement Date 19-05-18 20-05-23 21-05-08 22-04-29 23-05-23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Thyrocare Technologies Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
625.7 INR
Average target price
727.5 INR
Spread / Average Target
+16.27%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
THYROCARE TECHNOLOGIES LIMITED Stock Thyrocare Technologies Limited
-2.77% 397M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-16.58% 8.49B
RADNET, INC. Stock RadNet, Inc.
+58.90% 4.08B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.78% 2.42B
SYNLAB AG Stock SYNLAB AG
-10.33% 2.42B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-8.91% 2.33B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-2.53% 2.01B
FLEURY S.A. Stock Fleury S.A.
-19.90% 1.53B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-38.30% 1.26B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+2.19% 1.07B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. THYROCARE Stock
  4. Financials Thyrocare Technologies Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW